
Former Mitsui VCs launch $150m biopharma fund
Two former venture investors from Japanese trading company Mitsui & Co are looking to raise $150 million for a new fund focusing on the biopharmaceutical sector.
According to a regulatory filing, the new fund will call be Remiges Biopharma and will be headed by Taro Inaba, former general manager of Mitsui's healthcare and clean-tech investment department, and Walter Olesiak, who used to an investment partner with the same firm.
Inaba is understood to have left Mitsui in May while Olesiak is currently listed as a managing director at Connectis Ventures, having departed Mitsui in 2012.
Inaba and Olesiak were behind some of Mitsui's most notable investments in the biopharma space including Boston Biomedical, a developer of stem cell-based cancer therapeutics, which was sold to Japan's Dainippon Sumitomo Pharma in 2012 for around $2.6 billion.
Mitsui, as one of Japan's largest conglomerates, has a long record of VC investment in Asia and the US. It currently makes VC investments out of its subsidiary, Mitsui Global Investment, which grew out of Mitsui & Co. Venture Partners. Target sectors include IT, healthcare, retail and cleantech.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.